ERBB2 and neoplasm: Currently, HER2-positive invasive tumours are treated more aggressively regardless of its size.58 This may suggest that HER2-positive DCIS tumour cells although highly proliferative are not highly invasive, whilst those that acquire invasive properties became aggressive and can metastasise.